Countdown | Diabetes on the Net

Your web browser is out of date.

For your security and improved experience online, please update your browser.

Diabetes on the Net is intended for healthcare professionals

Thank you for registering for the webinar

We have sent you a confirmation email and look forward to welcoming you online.
We will send you a reminder email closer to the start of the broadcast.​

Count down to webinar

Wednesday 2 December 2020 7pm

Days
Hours
Minutes
Seconds
Your data is being collected by OmniaMed Communications on behalf of Novo Nordisk solely for the purpose of processing your registration.
Your details will not be shared with any parties other than OmniaMed Communications and Novo Nordisk
This is a promotional webinar that is organised and funded by Novo Nordisk.
The information presented at this meeting is intended for UK-based healthcare professionals.
Prescribing information for Saxenda® (liraglutide) can be accessed by clicking here.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Novo Nordisk Limited (Telephone Novo Nordisk Customer Care Centre 0845 6005055). Calls may be monitored for training purposes.

Job code: UK20SX00188  | Date of preparation: November 2020

Practical experiences from running an adeno-associated virus gene therapy trials: The Principal Investigator’s perspective

XX September 2020

Complete the registration form

XX Month 2020

Complete the registration form

We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.

* Mandatory Field
Your data is being collected by OmniaMed Communications on behalf of Novo Nordisk solely for the purpose of processing your registration. Your details will not be shared with any parties other than OmniaMed Communications and Novo Nordisk.